When a patient develops severe aortic stenosis, doctors at the Michigan Medicine Frankel Cardiovascular Center consider aortic valve replacement through a minimally invasive procedure known as TAVR, or transcatheter aortic valve replacement. During the procedure, a collapsible replacement valve is delivered to the valve site through a catheter inserted into an artery in the groin or arm. Traditionally offered to patients who were too sick for open heart surgery, TAVR is now available for moderate- and low-risk patients. Recovery time for a TAVR procedure is much shorter than for open heart surgery: 1 week versus 3 months. TAVR technology is also being used to restore the function of failing bioprosthetic valves and may be the best valve-replacement option for high-risk patients.
Michigan Medicine is one of the only health systems in the region to offer the full spectrum of TAVR valve options available through clinical trials as well as FDA-approved devices. Our collaborative TAVR team includes cardiologists, interventional cardiologists, cardiac surgeons, anesthesiologists, physician assistants and nurse practitioners. As a high-volume center with nearly 10 years of experience performing TAVR procedures, the Frankel Cardiovascular Center is one of the top programs in the country.
For more information, visit umcvc.org/TAVR or call 1-888-272-1082.
-------------------------------------------------------
Subscribe to Michigan Medicine’s YouTube channel for upcoming videos and future live streams featuring our experts answering your questions.
-------------------------------------------------------
Follow Michigan Medicine on Social:
Twitter:
Instagram:
Facebook:
Follow the U-M Frankel Cardiovascular Center on Social:
Twitter:
Facebook:
#TAVR #MichiganMedicine #Cardiovascular #Medicine #Health
0 Comments